개방각 녹내장 치료제 시장 2024-2028년
개방각 녹내장 치료제 시장은 2023-2028년에 23억 6,250만 달러, 예측 기간 중 CAGR은 6.1%로 성장할 것으로 예측됩니다. 개방각 녹내장 치료제 시장의 전체적인 분석, 시장 규모·예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 다룬 벤더 분석 등을 게재하고 있습니다.
현재 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공하고 있습니다. 시장은 녹내장 치료제의 유망 파이프라인과 최근 승인, 녹내장 치료를 위한 병용약의 수요 증가, 고령자 인구의 증가에 의해 촉진되고 있습니다.
| 시장 범위 |
| 기준년 |
2024 |
| 종료년 |
2028 |
| 예측 기간 |
2024-2028 |
| 성장 모멘텀 |
가속 |
| 전년대비 2024년 |
5.7% |
| CAGR |
6.1% |
| 증분액 |
23억 6,250만 달러 |
본 조사에서는 향후 수년간 개방각 녹내장 치료제 시장의 성장을 촉진하는 주요 요인의 하나로 녹내장 치료를 위한 생물제제의 개발을 들고 있습니다. 또한 세계의 개방각 녹내장 치료제 시장에서 제휴의 확대 및 녹내장에 대한 의식의 향상은 시장의 큰 수요로 연결됩니다.
목차
제1장 개요
제2장 시장 구도
제3장 시장 규모의 평가
- 시장의 정의
- 시장 부문 분석
- 시장 규모 2023년
- 시장 전망 2023-2028년
제4장 시장 규모 실적
- 세계의 개방각 녹내장 치료제 시장 2018-2022년
- 제품별 부문 분석 2018-2022년
- 채널별 부문 분석 2018-2022년
- 지역별 부문 분석 2018-2022년
- 국가별 부문 분석 2018-2022년
제5장 Five Forces 분석
- Five Forces 요약
- 바이어의 교섭력
- 공급 기업의 교섭력
- 신규 진출업체의 위협
- 대체품의 위협
- 경쟁의 위협
- 시장 현황
제6장 제품별 시장 세분화
- 시장 세분화
- 비교 : 제품별
- PGA : 시장 규모와 예측 2023-2028년
- 비PGA : 시장 규모와 예측 2023-2028년
- 제품별 시장 기회
제7장 채널별 시장 세분화
- 시장 세분화
- 비교 : 채널별
- 병원 약국 : 시장 규모와 예측 2023-2028년
- 소매 약국 : 시장 규모와 예측 2023-2028년
- 온라인 약국 : 시장 규모와 예측 2023-2028년
- 채널별 시장 기회
제8장 고객 상황
제9장 지역별 상황
- 지역별 세분화
- 지역별 비교
- 북미 : 시장 규모와 예측 2023-2028년
- 유럽 : 시장 규모와 예측 2023-2028년
- 아시아 : 시장 규모와 예측 2023-2028년
- 세계의 기타 지역 : 시장 규모와 예측 2023-2028년
- 미국 : 시장 규모와 예측 2023-2028년
- 캐나다 : 시장 규모와 예측 2023-2028년
- 중국 : 시장 규모와 예측 2023-2028년
- 영국 : 시장 규모와 예측 2023-2028년
- 독일 : 시장 규모와 예측 2023-2028년
- 지역 상황별 시장 기회
제10장 촉진요인·과제·기회·억제요인
- 시장 성장 촉진요인
- 시장이 해결해야 할 과제
- 촉진요인과 과제의 영향
- 시장의 기회·억제요인
제11장 경쟁 구도
제12장 경쟁 분석
- 기업 개요
- 기업의 시장 포지셔닝
- AbbVie Inc.
- Alcon Inc.
- Bausch Health Companies Inc.
- Hikma Pharmaceuticals Plc
- Inotek Pharmaceuticals
- Merck and Co. Inc.
- Nicox S.A.
- Novartis AG
- Otsuka Pharmaceutical Co. Ltd.
- Pfizer Inc.
- Santen Pharmaceutical Co. Ltd.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
제13장 부록
KSA
Open-angle Glaucoma Therapeutics Market 2024-2028
The open-angle glaucoma therapeutics market is forecasted to grow by USD 2362.5 mn during 2023-2028, accelerating at a CAGR of 6.1% during the forecast period. The report on the open-angle glaucoma therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by promising pipeline and recent approvals for glaucoma therapies, increasing demand for combination drugs for glaucoma treatment, and rising geriatric population.
| Market Scope |
|---|
| Base Year | 2024 |
| End Year | 2028 |
| Series Year | 2024-2028 |
| Growth Momentum | Accelerate |
| YOY 2024 | 5.7% |
| CAGR | 6.1% |
| Incremental Value | $2362.5 mn |
Technavio's open-angle glaucoma therapeutics market is segmented as below:
By Product
By Channel
- Hospital pharmacy
- Retail pharmacy
- Online pharmacy
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the development of biologics for glaucoma treatment as one of the prime reasons driving the open-angle glaucoma therapeutics market growth during the next few years. Also, growing alliances in global open-angle glaucoma therapeutics market and growing awareness about glaucoma will lead to sizable demand in the market.
The report on the open-angle glaucoma therapeutics market covers the following areas:
- Open-angle glaucoma therapeutics market sizing
- Open-angle glaucoma therapeutics market forecast
- Open-angle glaucoma therapeutics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading open-angle glaucoma therapeutics market vendors that include AbbVie Inc., Alcon Inc., Bausch Health Companies Inc., Hikma Pharmaceuticals Plc, Inotek Pharmaceuticals, Merck and Co. Inc., Nicox S.A., Novartis AG, Otsuka Pharmaceutical Co. Ltd., Pfizer Inc., Santen Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.. Also, the open-angle glaucoma therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Channel
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 2.2 Market characteristics
- Market characteristics analysis
- 2.3 Value chain analysis
3 Market Sizing
- 3.1 Market definition
- Offerings of companies included in the market definition
- 3.2 Market segment analysis
- 3.3 Market size 2023
- 3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
- 4.1 Global Open-Angle Glaucoma Therapeutics Market 2018 - 2022
- Historic Market Size - Data Table on Global Open-Angle Glaucoma Therapeutics Market 2018 - 2022 ($ million)
- 4.2 Product segment analysis 2018 - 2022
- Historic Market Size - Product Segment 2018 - 2022 ($ million)
- 4.3 Channel segment analysis 2018 - 2022
- Historic Market Size - Channel Segment 2018 - 2022 ($ million)
- 4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- 4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
- 5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product
- 6.1 Market segments
- Chart on Product - Market share 2023-2028 (%)
- Data Table on Product - Market share 2023-2028 (%)
- 6.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
- 6.3 PGAs - Market size and forecast 2023-2028
- Chart on PGAs - Market size and forecast 2023-2028 ($ million)
- Data Table on PGAs - Market size and forecast 2023-2028 ($ million)
- Chart on PGAs - Year-over-year growth 2023-2028 (%)
- Data Table on PGAs - Year-over-year growth 2023-2028 (%)
- 6.4 Non-PGAs - Market size and forecast 2023-2028
- Chart on Non-PGAs - Market size and forecast 2023-2028 ($ million)
- Data Table on Non-PGAs - Market size and forecast 2023-2028 ($ million)
- Chart on Non-PGAs - Year-over-year growth 2023-2028 (%)
- Data Table on Non-PGAs - Year-over-year growth 2023-2028 (%)
- 6.5 Market opportunity by Product
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)
7 Market Segmentation by Channel
- 7.1 Market segments
- Chart on Channel - Market share 2023-2028 (%)
- Data Table on Channel - Market share 2023-2028 (%)
- 7.2 Comparison by Channel
- Chart on Comparison by Channel
- Data Table on Comparison by Channel
- 7.3 Hospital pharmacy - Market size and forecast 2023-2028
- Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
- Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
- Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
- Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
- 7.4 Retail pharmacy - Market size and forecast 2023-2028
- Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
- Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
- Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
- Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
- 7.5 Online pharmacy - Market size and forecast 2023-2028
- Chart on Online pharmacy - Market size and forecast 2023-2028 ($ million)
- Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ million)
- Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
- Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
- 7.6 Market opportunity by Channel
- Market opportunity by Channel ($ million)
- Data Table on Market opportunity by Channel ($ million)
8 Customer Landscape
- 8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
- 9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
- 9.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 9.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 9.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
- 9.8 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
- 9.9 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
- 9.10 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
- 9.11 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 9.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
- 10.4 Market opportunities/restraints
11 Competitive Landscape
- 11.1 Overview
- 11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 11.3 Landscape disruption
- Overview on factors of disruption
- 11.4 Industry risks
- Impact of key risks on business
12 Competitive Analysis
- 12.1 Companies profiled
- 12.2 Market positioning of companies
- Matrix on companies position and classification
- 12.3 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- 12.4 Alcon Inc.
- Alcon Inc. - Overview
- Alcon Inc. - Business segments
- Alcon Inc. - Key news
- Alcon Inc. - Key offerings
- Alcon Inc. - Segment focus
- 12.5 Bausch Health Companies Inc.
- Bausch Health Companies Inc. - Overview
- Bausch Health Companies Inc. - Business segments
- Bausch Health Companies Inc. - Key news
- Bausch Health Companies Inc. - Key offerings
- Bausch Health Companies Inc. - Segment focus
- 12.6 Hikma Pharmaceuticals Plc
- Hikma Pharmaceuticals Plc - Overview
- Hikma Pharmaceuticals Plc - Business segments
- Hikma Pharmaceuticals Plc - Key news
- Hikma Pharmaceuticals Plc - Key offerings
- Hikma Pharmaceuticals Plc - Segment focus
- 12.7 Inotek Pharmaceuticals
- Inotek Pharmaceuticals - Overview
- Inotek Pharmaceuticals - Product / Service
- Inotek Pharmaceuticals - Key offerings
- 12.8 Merck and Co. Inc.
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- 12.9 Nicox S.A.
- Nicox S.A. - Overview
- Nicox S.A. - Key offerings
- 12.10 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- 12.11 Otsuka Pharmaceutical Co. Ltd.
- Otsuka Pharmaceutical Co. Ltd. - Overview
- Otsuka Pharmaceutical Co. Ltd. - Product / Service
- Otsuka Pharmaceutical Co. Ltd. - Key offerings
- 12.12 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- 12.13 Santen Pharmaceutical Co. Ltd.
- Santen Pharmaceutical Co. Ltd. - Overview
- Santen Pharmaceutical Co. Ltd. - Product / Service
- Santen Pharmaceutical Co. Ltd. - Key offerings
- 12.14 Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd. - Overview
- Sun Pharmaceutical Industries Ltd. - Product / Service
- Sun Pharmaceutical Industries Ltd. - Key news
- Sun Pharmaceutical Industries Ltd. - Key offerings
- 12.15 Teva Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd. - Overview
- Teva Pharmaceutical Industries Ltd. - Business segments
- Teva Pharmaceutical Industries Ltd. - Key news
- Teva Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd. - Segment focus
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 13.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 13.4 Research methodology
- 13.5 Data procurement
- 13.6 Data validation
- 13.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 13.8 Data synthesis
- 13.9 360 degree market analysis
- 360 degree market analysis
- 13.10 List of abbreviations
